[Use of metoclopramide and dexamethasone in preventing vomiting associated with antineoplastic chemotherapy].
W
W
Sobkowski
J
J
Jassem
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008787:Metoclopramide / Q000008:administration & dosage*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D008787:Metoclopramide; D002945:Cisplatin
Zastosowanie metoklopramidu i deksametazonu w zapobieganiu wymiotom towarzyszacym chemioterapii przeciwnowotworowej.